---
title: "Adyen partners with LillyDirect to provide payment technology services"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294828458.md"
description: "Adyen has partnered with Eli Lilly to provide payment technology services for the LillyDirect platform, which facilitates home delivery of FDA-approved medicines. Adyen will support card payments, digital wallets, HSA/FSA cards, fraud prevention, and analytics. The partnership utilizes Adyen Intelligent Payment Routing to automatically select U.S. debit networks, aiming to improve transaction authorization performance without additional integration efforts."
datetime: "2026-08-04T12:57:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294828458.md)
  - [en](https://longbridge.com/en/news/294828458.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294828458.md)
generator: "portal-rs"
---

# Adyen partners with LillyDirect to provide payment technology services

-   Adyen will provide payment technology services for Eli Lilly’s LillyDirect platform for prescribed patients accessing FDA-approved medicines with home delivery. \* LillyDirect will use Adyen to support card payments, digital wallets, HSA/FSA cards, fraud prevention, reconciliation, analytics. \* Transactions will use Adyen Intelligent Payment Routing to select U.S. debit networks automatically, aiming to improve authorization performance without added integration. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adyen NV published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ADYEY.US](https://longbridge.com/en/quote/ADYEY.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)

## Related News & Research

- [Eli Lilly Is Acquiring Merdia Biosciences for Up to $2.88 Billion. Here's What That Means for Investors.](https://longbridge.com/en/news/297565544.md)
- [Lilly's $9.94 Billion Mounjaro Franchise Wins a Heart-Risk Label](https://longbridge.com/en/news/297356212.md)
- [Obesity Drug Alert: Eli Lilly Study Shows Sustained Zepbound Treatment Reduces Hospital Visits, Medical Costs](https://longbridge.com/en/news/297082109.md)
- [Eli Lilly's Taltz-Zepbound Combo Shows Encouraging Results At Week 52](https://longbridge.com/en/news/297510647.md)
- [Evolve Private Wealth LLC Lowers Stock Holdings in Eli Lilly and Company $LLY](https://longbridge.com/en/news/297282696.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**